Abstract

Aptamers are in vitro selected DNA or RNA molecules that are capable of binding a wide range of nucleic and non-nucleic acid molecules with high affinity and specificity. They have been conducted through the process known as SELEX (Systematic Evolution of Ligands by Exponential Enrichment). It serves to reach specificity and considerable affinity to target molecules, including those of viral origin, both proteins and nucleic acids. Properties of aptamers allow detecting virus infected cells or viruses themselves and make them competitive to monoclonal antibodies. Specific aptamers can be used to interfere in each stage of the viral replication cycle and also inhibit its penetration into cells. Many current studies have reported possible application of aptamers as a treatment or diagnostic tool in viral infections, e.g., HIV (Human Immunodeficiency Virus), HBV (Hepatitis B Virus), HCV (Hepatitis C Virus), SARS (Severe Acute Respiratory Syndrome), H5N1 avian influenza and recently spread Ebola. This review presents current developments of using aptamers in the diagnostics and treatment of viral diseases.

Highlights

  • Aptamers are single strand nucleic acid molecules, consisting of DNA or RNA that bind to organic or nonorganic molecules—from single atoms to a wide range of proteins

  • Lee et al reported the construction of a biosensor utilizing the fluorescent dye (Cyanine3) RNA aptamer directed against HCV core antigen [43], while Chen et al obtained the aptamer that bound viral glycoprotein E2 [26]

  • Aptamers, from which aptamer 10 strongly bound HA1 subunit of dangerous strain H5N1 avian influenza virus. As it was demonstrated by MTT assay in Madin-Darby Canine Kidney (MDCK) cells culture, application of aptamer slowed down the progress of the infection

Read more

Summary

Introduction

Aptamers are single strand nucleic acid molecules, consisted of DNA or RNA, which bind to organic or nonorganic molecules with high specificity and affinity. Aptamers are generated in the method referred to as Systematic Evolution of Ligands by Exponential Enrichment (SELEX). Properties of aptamers make them competitive to monoclonal antibodies used in conventional laboratory practice. The first pharmaceutical aptamer, Macugen (pegaptanib sodium) has been admitted by US. Agency for Food and Drug Administration (FDA) for the treatment of Age-Related Macular

Aptamer in the Diagnostics of Viral Infections
Future Perspectives of Aptamers in Diagnostic Procedures
Aptamers in the Treatment of Viral Infections
Blocking of Viral Fusion with the Target Cell
Blocking of Viral Enzymes with Polymerase Activity
Blocking the Activity of Other Enzymes Involved in Viral Replication
Blocking the Nucleocapsid Protein of HIV-1
Inhibition of Nucleic Acid Sequences Essential for Virus Replication Cycle
Delivery of Therapeutic Molecules to Cells Infected with Viruses
Other Strategies
Aptamers against Ebola Infection
Aptamers—“For” and “against”
Aptamer’s Stability under Physiological Conditions
Renal Clearance
Toxicity
Conclusions
Aptamers in the Diagnostics of Viral Infections
Findings
Aptamers in the Viral Infections Treatment
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call